$AMN is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 12 active Congressional signals mentioning $AMN, including 9 bills and 3 federal contracts. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.
HR8272, introduced April 14, 2026, proposes classifying locum tenens and advanced care practitioners as independent contractors under the FLSA and NLRA. The bill is at the earliest legislative stage, referred to committee with zero appropriations. Passage probability is low. The primary beneficiaries — healthcare staffing firms like AMN Healthcare — see no near-term revenue impact. The bill has not moved markets.
→ Removes legal risk of misclassification lawsuits and associated wage/hour penalties for staffing firms; reduces labor cost overhead for temporary clinicians by eliminating overtime, minimum wage, and unionization exposure for these placements.
HR7787 is an early-stage bill authorizing a mental health provider loan forgiveness program. It has been referred to committee with no companion bill, zero appropriations, and minimal legislative momentum. Market impact is negligible at this stage. Real market data shows AMN Healthcare at $20.65, up 12.6% over 30 days, and Centene at $53.22, up 62.55% over 30 days, driven by other factors unrelated to this procedural bill.
→ No direct economic effect until and unless appropriations are passed; the program would increase supply of mental health providers in shortage areas, potentially reducing demand for temporary staffing solutions over a multi-year horizon.
S.3033 mandates VA-rural hospital partnerships, creating revenue tailwinds for rural hospital operators ($HCA, $UHS) and healthcare staffing ($AMN) through mandatory co-location, leasing, and telehealth agreements. The bill is out of committee with bipartisan sponsorship but lacks funding authorization — actual impact requires future appropriations. Recent market data shows $AMN up 12.2% in 30 days, while $HCA and $UHS have declined sharply on separate sector pressures.
→ increased demand for temporary healthcare staffing (nurses, allied health professionals) in rural locations as VA and partner facilities staff up new co-located clinics and telehealth hubs
The Fast Track Healthcare Apprenticeships Act (S.3364) mandates a 45-day registration timeline and digital forms for healthcare apprenticeships, reducing labor shortages in the sector. The bill is in early stage (referred to committee), but its bipartisan companion and moderate momentum signal potential passage. AMN Healthcare and Robert Half are positioned to benefit from increased workforce supply and digital implementation demand.
→ Reduced administrative barriers and faster approval for healthcare apprenticeship programs will increase the volume of new apprentices entering the workforce, directly addressing labor shortages in healthcare staffing.
S.3607 expands Medicare Part B to cover genetic counseling as a new provider category effective Jan 1, 2027, directly increasing the addressable patient population for genetic testing. This is a structural positive for Labcorp ($LH) and Quest Diagnostics ($DGX) through higher test volume, and for AMN Healthcare ($AMN) through increased demand for scarce genetic counselors. The bill is at early legislative stage (referred to Finance Committee) with companion bill HR6280 in the House.
→ As Medicare coverage creates a clear reimbursement pathway, healthcare providers will increase hiring of genetic counselors; the supply of board-certified genetic counselors is limited (~5,000 in the US), creating upward pressure on staffing demand and rates
HR 6894 is an early-stage, low-probability bill that expands Medicare cardiac and pulmonary rehab supervision to PAs, NPs, and CNSs. It authorizes zero funding and remains in committee. Marginal upside for healthcare staffing firm AMN (allied health demand) is possible but contingent on passage. Labcorp (LH) sees no structural impact. Current market prices: AMN $20.62, LH $262.99.
→ Expands the pool of eligible prescribers and supervisors for these rehabilitation programs, potentially increasing patient access and the volume of billable rehab sessions. No new funding or reimbursement rate change is authorized.
The SAFE Act expands Medicare to cover fall risk assessments and prevention services provided by physical and occupational therapists, effective January 2026. This creates a new reimbursable service line for outpatient therapy clinics like $USPH and increases staffing demand for agencies like $AMN. The bill is in early committee stage with bipartisan support (51 cosponsors) and a Senate companion, but no funding is authorized.
→ Providers will need additional physical and occupational therapists to satisfy incremental patient volume from new fall risk assessments and prevention services, increasing staffing agency placements.
HR3482 is a procedural authorization bill requiring the VA to build an online scheduling system for community care appointments. It mandates an IT system change but includes no explicit funding, and it does not directly increase patient volume or reimbursement rates. The market impact on healthcare stocks ($DGX, $LH, $HCA, $UHS, $AMN) is negligible in the near term.
HR3415 mandates federal hospital nurse-to-patient ratios, imposing significant new labor costs on hospital operators ($HCA, $UHS, $THC, $CYH) while creating a structural tailwind for healthcare staffing firms ($AMN, $RHI). The bill has 40 cosponsors and a Senate companion, signaling meaningful advancement probability despite early legislative stage. Real market data confirms the trend: hospital stocks have declined 2-8% in 30 days, staffing firms have risen 5-14%.
→ Hospitals facing mandatory ratios will accelerate use of contract/travel nurses as a stopgap while permanent recruitment lags; AMN benefits from both higher volume and likely increased pricing power as demand for temporary RNs outstrips supply.